Adult Obesity Prevalence: Race, Ethnicity and 2035 Forecast. Racial Disparities, Health Risks and Prevention Strategies

Introduction

Imagine a country where every other adult you meet is living with obesity. According to a landmark study published in JAMA in January 2026, that scenario is less than a decade away for the United States. Researchers from the Institute for Health Metrics and Evaluation at the University of Washington analyzed data from over 11 million Americans and found that adult obesity prevalence has more than doubled since 1990 and the numbers show no sign of stopping.

In 2022, approximately 107 million American adults, or 42.5% of the population, were living with obesity. By 2035, that figure is projected to reach nearly 47%, or 126 million people. These are not abstract statistics. They represent real individuals facing higher risks of heart disease, type 2 diabetes, cancer and early death.

What makes this study especially powerful is what it reveals about who is most affected. Obesity is not distributed equally across the American population. Race, ethnicity, sex, age and geography all shape a person’s risk in ways that go far beyond personal choice. Understanding these patterns is the first step toward meaningful prevention. This article breaks down the science clearly, using simple language, so you can understand what is happening, why it matters, and what can actually help.

The Numbers Don’t Lie: Obesity Has More Than Doubled

To understand where America stands today, it helps to look back to where it started. In 1990, roughly 34.7 million American adults, about 19.3% of the population, had obesity, defined as a body mass index (BMI) of 30 or higher. By 2022, that number had grown to 107 million adults, or 42.5% of the population. In practical terms, obesity more than doubled in just 30 years.

This is part of a global pattern. A massive pooled analysis published in The Lancet by the NCD Risk Factor Collaboration— which studied 222 million people across 200 countries — found that worldwide obesity rates have followed the same alarming trajectory since 1990. More than one billion people globally are now living with obesity. In the United States, the numbers are among the worst in the world.

The JAMA study by DeCleene and colleagues used a sophisticated method to reach these conclusions. The researchers combined data from three major surveys: the Behavioral Risk Factor Surveillance System (BRFSS), the Gallup Daily Survey and the National Health and Nutrition Examination Survey (NHANES). Because people tend to underestimate their weight when reporting it themselves, the team used NHANES, which involves actual physical measurements, to correct for this bias. The result is one of the most accurate state-level estimates of adult obesity ever produced.

Here are the key findings at a glance:

1990: 34.7 million adults with obesity (19.3% of the population)
2022: 107 million adults with obesity (42.5% of the population)
2035 projection: 126 million adults with obesity (46.9% of the population)
Most affected group in 2022: Non-Hispanic Black women, at 56.9%
Least affected group in 2022: Non-Hispanic White men, at 40.1%
State with highest female obesity in 2022: Oklahoma (54%)
State with highest male obesity in 2022: Indiana (47%)

These numbers also reveal something important about age. Adults between 45 and 64 years had the highest obesity rates overall. However, the fastest increases occurred in younger adults, especially women in their late 20s and early 30s. This represents an earlier onset of obesity than previous generations experienced, which will likely compound health consequences over time. You can read more about the specific challenges of weight gain during middle age in another article on this site.

Race, Ethnicity and the Unequal Burden of Obesity

Perhaps the most striking finding in the JAMA study is just how unequally obesity is distributed across racial and ethnic groups. In 2022, adult obesity prevalence at the national level ranged from 40.1% among non-Hispanic White men to 56.9% among non-Hispanic Black women. That is a 17-percentage-point gap between two groups living in the same country.

Among women, the disparities are especially stark:

Non-Hispanic Black women: 57% obesity prevalence in 2022 — the highest of any group
Hispanic women: Nearly 49.4%, up dramatically from 24.2% in 1990
Non-Hispanic White women: Significant increases, especially in younger age groups
Asian women: Consistently lower rates, though still rising

Among men, Hispanic males saw the largest absolute increase, rising from 17.4% in 1990 to 42.6% in 2022. Non-Hispanic Black men showed the smallest increase among male groups, though their absolute rates remain high.

The age dimension adds another layer. Among women aged 25 to 29, Black women saw their obesity rates nearly double, from 26% to 53%. Hispanic women and White women between ages 30 and 34 also experienced some of the largest increases in the entire study population.

Why do these racial and ethnic disparities exist? The researchers are clear that the causes are complex, structural, and multifactorial. They include:

Discrimination based on race and ethnicity, which contributes to chronic stress that alters metabolism
Food insecurity and unequal access to affordable, nutritious food
Socioeconomic deprivation, including lower income and education levels linked to higher obesity rates
Inequities in physical activity access due to neighborhood design — fewer safe parks, walking paths, and recreational facilities in low-income and minority communities
Healthcare disparities, including lower rates of preventive care and access to obesity treatment

These are not individual failures. They are systemic failures that accumulate across a lifetime. Understanding this is essential for building compassionate, effective solutions. The connection between stress and metabolic dysfunction, including how chronic stress raises cortisol and promotes fat storage, helps explain part of this picture.

Geography Matters: Where You Live Shapes Your Risk

The JAMA study went beyond national averages to map obesity by individual US state. The results reveal a geographic pattern that has significant implications for public health policy.

The highest obesity rates were consistently found in Midwestern and Southern states. In 2022, Oklahoma had the highest rate of female obesity at 54%, and Indiana had the highest rate of male obesity at 47%. States like Mississippi, West Virginia, and Arkansas have historically ranked among the heaviest in the nation.

The lowest obesity rates were found in Western and Northeastern states. Colorado stood out consistently, it had both one of the lowest obesity rates in the country and the lowest reported prevalence of physical inactivity. This association between active lifestyles and lower obesity underscores the importance of environment in shaping behavior.

Looking forward to 2035, the geographic picture is shifting in unexpected ways. The researchers found that states which historically had very high obesity rates, like Mississippi, may be experiencing a plateau. Meanwhile, other states like Oklahoma and South Dakota are projected to see significant increases. By 2035, South Dakota is projected to have the highest female obesity rate at 60%, and Indiana is expected to retain the top spot for men at 54%.

These geographic differences reflect interactions between food environments, built environments, economic conditions, and cultural norms. For example:

💡 Key Insight: States with consistently high obesity rates also tend to have the lowest percentage of residents meeting dietary recommendations. Access to healthy food is not just a personal choice, it is shaped by where grocery stores are located, what foods are affordable and what communities have historically been underserved.

A parallel pattern exists globally. The Global Burden of Disease forecasting study published in The Lancet in 2025projects that more than half the world’s population, over 4 billion people, will be affected by overweight and obesity by 2035 if current trends continue. Low- and middle-income countries face a particularly difficult challenge, combining rising obesity with persistent undernutrition.

Why Obesity Is Much More Than a Weight Problem

It would be a mistake to treat obesity as simply a cosmetic or lifestyle issue. The medical and scientific community has reached a clear consensus: obesity is a chronic, systemic disease with devastating consequences for virtually every organ system in the body.

In January 2025, the Lancet Diabetes and Endocrinology Commission published a landmark document signed by 58 medical experts from multiple specialties worldwide. They defined clinical obesity as a chronic, systemic illness caused by excess body fat that directly affects the function of organs and tissues. They also introduced the concept of preclinical obesity, excess body fat with normal organ function, but carrying elevated risk for future disease.

This distinction matters enormously. It means that not everyone with a high BMI has the same level of risk, and that treatment should be tailored accordingly. The traditional approach of treating everyone with obesity as equally ill, or equally healthy, is now medically outdated.

What are the actual health consequences of obesity? The Global Burden of Disease Study, published in the New England Journal of Medicine, analyzed data from 195 countries over 25 years and found convincing evidence linking obesity to at least 20 different health conditions. These include:

Cardiovascular disease: 41% of all obesity-related deaths globally are due to heart disease, making it the #1 killer among people with obesity
Type 2 diabetes: Obesity is the single most powerful driver of the global diabetes epidemic
Certain cancers: Including endometrial, colorectal, postmenopausal breast, kidney, liver, and pancreatic cancers
Sleep apnea, hypertension, nonalcoholic fatty liver disease, osteoarthritis, and kidney disease

Metabolic syndrome, the dangerous cluster of high blood sugar, high blood pressure, abnormal cholesterol, and abdominal obesity, is both a consequence and a driver of the obesity epidemic. It dramatically amplifies cardiovascular and diabetes risk.

The economic consequences are equally staggering. Rough global estimates suggest obesity accounts for over $700 billion annually in healthcare costs, with the United States alone incurring approximately $100 billion per year. In Western countries, obesity treatment absorbs between 8% and 9% of total healthcare expenditure.

For individuals, living with obesity affects quality of life, mobility, mental health, and productivity. The Lancet Commission explicitly noted that people with clinical obesity can be denied access to care due to systemic policy failures, a paradox where those with the greatest need face the greatest barriers to treatment.

What Is Driving the Obesity Crisis in America?

Understanding the root causes of the obesity epidemic requires moving beyond simplistic explanations. The science points to a complex web of biological, environmental, commercial, and structural drivers that interact across time.

Biological factors include genetics, hormonal regulation of appetite, and the way fat tissue functions. The body has powerful mechanisms to defend against weight loss, which is why lifestyle interventions alone often fail in the long term. Research on gene-environment interactions shows that genetic susceptibility to obesity is significantly modified by physical activity, meaning that the same genes may produce obesity in an inactive environment but not in an active one.

Environmental factors are perhaps the most actionable. The food environment in the United States has changed radically since 1990. Ultra-processed foods are cheaper, more available, and more aggressively marketed than whole foods. “Food deserts”, neighborhoods with little access to fresh produce and healthy options, disproportionately affect low-income and minority communities. Meanwhile, urban design in many American cities makes walking, cycling, and outdoor activity difficult or unsafe.

Commercial determinants of obesity, the role of the food and beverage industry in shaping what people eat, deserve particular attention. The 2019 Lancet Commission on the global syndemic of obesity described how transnational food companies systematically drive unhealthy consumption patterns through advertising, product design, and political lobbying.

Chronic stress plays an underappreciated role. Elevated cortisol levels, a direct result of stress, discrimination, financial insecurity, and trauma, promote fat storage, particularly in the abdominal region. This creates a biological pathway connecting social inequality to obesity risk.

Sleep deprivation disrupts hormones that regulate hunger and satiety, specifically ghrelin (which increases appetite) and leptin (which signals fullness). This connection between poor sleep and weight gain is well established in the scientific literature.

What can actually help? The research points to several evidence-based approaches:

Nutritional strategies that reduce ultra-processed food intake and increase whole foods, fruits, vegetables, and lean protein. Time-restricted eating has shown promise in recent meta-analyses as a practical tool for weight management.
Regular physical activity, ideally 150–300 minutes of moderate aerobic exercise per week combined with resistance training, as recommended by major health organizations.
Pharmacological treatment — the arrival of revolutionary anti-obesity medications like GLP-1 receptor agonists (semaglutide, tirzepatide) has transformed the treatment landscape. These drugs produce sustained weight loss of 15–20% of body weight in clinical trials and also reduce cardiovascular events.
Bariatric surgery remains the most effective and durable treatment for severe obesity, with proven benefits for heart health, kidney function, and cancer risk reduction.
Policy-level interventions that address food environments, urban design, socioeconomic inequality, and healthcare access are essential for population-level change.

The 2025 Dietary Guidelines and the work of nutrition scientists worldwide have increasingly focused on the gap between what the evidence recommends and what public health policy actually implements. Closing that gap is a political and institutional challenge as much as a scientific one.

It is also important to acknowledge what the lower obesity rates at older ages actually mean. The JAMA researchers noted that this likely reflects premature mortality, older adults with obesity die younger, reducing the apparent prevalence in that age group. This is not reassuring. It is a warning.

Conclusion

The adult obesity prevalence data from 1990 to 2022 tells a clear and urgent story: the United States is in the grip of a chronic disease epidemic that touches every state, every demographic group, and virtually every organ system. The projection that nearly half of all American adults will be living with obesity by 2035 is not inevitable, but reversing it requires honest acknowledgment of the problem and evidence-based action at every level.

The racial and ethnic disparities documented in this research are not a side note. They are central to the crisis. Black women, Hispanic women, and younger adults are bearing a disproportionate burden that reflects decades of structural inequality. Effective solutions must address these inequities directly, not merely apply one-size-fits-all interventions.

The good news is that science is progressing rapidly. New medications are delivering unprecedented weight loss results. Bariatric surgery continues to show long-term benefits. And growing awareness of how food environments, chronic stress, and socioeconomic factors drive obesity is opening doors for better policy.

For individuals, the most powerful tools remain accessible: eating a balanced, whole-food diet, staying physically active, managing stress and seeking medical care early. Understanding the full picture, the biology, the disparities, and the systemic drivers, empowers better decisions for yourself and your community.

The 2035 forecast is alarming. But with the right knowledge and collective action, it is a future we can still change.

References

DeCleene NK, Kahn E, Yuan CW, et al. US state-level prevalence of adult obesity by race and ethnicity from 1990 to 2022 and forecasted to 2035. JAMA. 2026 Jan 28. doi:10.1001/jama.2025.26817
NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults. Lancet. 2024;403(10431):1027-1050. doi:10.1016/S0140-6736(23)02750-2
GBD 2021 Collaborators. Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050. Lancet. 2025. doi:10.1016/S0140-6736(25)00355-1
Rubino F, Cummings DE, et al. Definition and diagnostic criteria of clinical obesity. Lancet Diabetes Endocrinol. 2025. doi:10.1016/S2213-8587(24)00316-4
GBD 2015 Obesity Collaborators. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377(1):13-27. doi:10.1056/NEJMoa1614362
Ward ZJ, et al. National-level and state-level prevalence of overweight and obesity among children, adolescents, and adults in the USA, 1990–2021, and forecasts up to 2050. Lancet. 2024. doi:10.1016/S0140-6736(24)01548-4
Loos RJF, et al. Obesity in adults. Lancet. 2024. doi:10.1016/S0140-6736(24)01210-8
Emmerich SD, Fryar CD, Stierman B, Ogden CL. Obesity and severe obesity prevalence in adults: United States, August 2021–August 2023. NCHS Data Brief. 2024;(508).
Mesquita LA, Wayerbacher LF, et al. Obesity, diabetes, and cancer: epidemiology, pathophysiology, and potential interventions. Arch Endocrinol Metab. 2023;67(6):e000647. doi:10.20945/2359-3997000000647